Improving cancer survivorship care delivery in Latino survivors: telehealth & lay health educators
Improving cancer survivorship care delivery in Latino survivors: telehealth & lay health educators
批准号:
10603034
负责人:
Eric Jessen Chow
金额:
$13.7万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-21 至 2024-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
In this R21 application, we address NCI’s Provocative Question #8 by proposing a pilot randomized clinical trial
to test an innovative strategy of using telehealth and bilingual lay health educators to provide linguistically and
culturally appropriate cancer survivorship care for Latinos. Latinos are now the largest minority population in the
US. However, compared with non-Latino Whites, they continue to experience significant disparities in cancer
care, including survivorship care. These disparities are attributable to a multitude of systemic and cultural factors
and contribute to a greater burden of cancer-related comorbidities and a lower quality of life. Factors that may
be amenable to interventions include disparities in patient-provider communication, due in part to language
barriers and limited culture competence among healthcare providers. Survivorship care plans (SCPs) may
improve patient knowledge of survivorship issues and improve coordination between oncology specialists and
primary care providers. They have been recommended by the National Academy of Medicine along with multiple
national and professional organizations. However, the delivery of SCPs in a comprehensive fashion has been
difficult, especially in under-resourced settings. Overall, research into the Latino cancer survivorship experience
has been limited, with few studies examining the impact of SCPs among Latino survivors. Most studies have
focused only on breast cancer survivors, and often feature resource-intensive oncology nursing or physician-led
interventions. To address these gaps in knowledge, we propose to recruit a mixture of urban and rural Latino
cancer survivors of the 5 most common cancer histologies (breast, colorectal, lung, lymphoma, and prostate)
from academic- and community-based oncology clinics in Washington State. Our specific goals are to determine,
in randomized fashion, the feasibility and preliminary efficacy of SCPs delivered using remote-based lay health
educators vs SCPs alone, with a focus on whether proximal outcomes (survivors’ knowledge of their cancer
history and their self-efficacy towards their follow-up care needs) can be improved. The proposal leverages NCI’s
Cancer Information Service, with its pool of survivorship-trained, bilingual, lay health educators. We also
propose, using a mixed-method approach, to obtain feedback from study participants (Latino cancer survivors)
via qualitative semi-structured interviews, and to assess their primary care providers’ knowledge and self-efficacy
regarding survivorship care. Finally, we will apply the Promoting Action on Research Implementation in Health
Services (PARIHS) implementation science framework to inform future implementation strategies to integrate
SCP delivery and more comprehensive survivorship care for Latino cancer survivors into routine care. The results
of this multi-level proposal will provide key preliminary data to inform the development and application of a larger,
robustly powered randomized clinical trial, as well as complementary strategies to facilitate the development of
effective and sustainable survivorship care for Latino cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SALSA - Study of Active Lifestyle Activation
-
批准号:10910785
-
项目类别:
-
资助金额:$19.95万
-
财政年份:2021
-
负责人:Eric Jessen Chow
-
依托单位:
SALSA - Study of Active Lifestyle Activation
-
批准号:10285925
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2021
-
负责人:Eric Jessen Chow
-
依托单位:
SALSA - Study of Active Lifestyle Activation
-
批准号:10601394
-
项目类别:
-
资助金额:$51.9万
-
财政年份:2021
-
负责人:Eric Jessen Chow
-
依托单位:
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
-
批准号:9220377
-
项目类别:
-
资助金额:$74.26万
-
财政年份:2017
-
负责人:Eric Jessen Chow
-
依托单位:
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
-
批准号:9891037
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2017
-
负责人:Eric Jessen Chow
-
依托单位:
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
-
批准号:10656913
-
项目类别:
-
资助金额:$45.56万
-
财政年份:2017
-
负责人:Eric Jessen Chow
-
依托单位:
Improving treatment of cardiovascular risk factors in childhood cancer survivors
-
批准号:10603027
-
项目类别:
-
资助金额:$48.79万
-
财政年份:2017
-
负责人:Eric Jessen Chow
-
依托单位:
Analysis of Morbidity and Mortality Among Hematopoietic Cell Transplantation Surv
-
批准号:8641672
-
项目类别:
-
资助金额:$8.54万
-
财政年份:2013
-
负责人:Eric Jessen Chow
-
依托单位:
Analysis of Morbidity and Mortality Among Hematopoietic Cell Transplantation Surv
-
批准号:8513119
-
项目类别:
-
资助金额:$8.8万
-
财政年份:2013
-
负责人:Eric Jessen Chow
-
依托单位:
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
-
批准号:8893907
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2011
-
负责人:Eric Jessen Chow
-
依托单位:
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
-
批准号:8699021
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2011
-
负责人:Eric Jessen Chow
-
依托单位:
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
-
批准号:8111884
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2011
-
负责人:Eric Jessen Chow
-
依托单位:
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
-
批准号:8308372
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2011
-
负责人:Eric Jessen Chow
-
依托单位:
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
-
批准号:8509622
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2011
-
负责人:Eric Jessen Chow
-
依托单位:
Shared Resource: Prevention Center
-
批准号:10636799
-
项目类别:
-
资助金额:$21.37万
-
财政年份:1997
-
负责人:Eric Jessen Chow
-
依托单位:
Shared Resource: Prevention Center
-
批准号:10319037
-
项目类别:
-
资助金额:$21.37万
-
财政年份:1997
-
负责人:Eric Jessen Chow
-
依托单位:
国内基金
海外基金
登录
查看更多内容
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
-
批准号:82371223
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:闻大翔
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
-
批准号:82372089
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李万万
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
-
批准号:82372724
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:何竑超
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
EGFR通过激活β-catenin重塑肿瘤微环境代谢调控肿瘤免疫逃逸的分子机制研究
-
批准号:32100574
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邵飞
-
依托单位:
脯氨酸羟化酶EglN1转位到线粒体介导乳腺癌细胞适应缺氧应激的机制研究
-
批准号:32100570
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:闫朝君
-
依托单位: